{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:07:21Z","timestamp":1780106841328,"version":"3.54.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003033","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008539","name":"CurePSP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.omtn.2026.102843","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:29:29Z","timestamp":1769128169000},"page":"102843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Artificial microRNAs targeting tau enable post-symptomatic functional recovery in aged tauopathy mice"],"prefix":"10.1016","volume":"37","author":[{"given":"Carolina Luc\u00eda","family":"Facal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indiana","family":"P\u00e1ez-Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Ezequiel","family":"Pereyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Gaguine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Clerici-Delville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Foltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Soiza-Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0251-0093","authenticated-orcid":false,"given":"Mar\u00eda Elena","family":"Avale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.102843_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","author":"Spillantini","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.omtn.2026.102843_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of tau protein in health and disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.omtn.2026.102843_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","article-title":"The many faces of tau","volume":"70","author":"Morris","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2026.102843_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.brainresbull.2016.08.003","article-title":"Special issue on \u2018Cytoskeletal proteins in health and neurodegenerative disease\u2019","volume":"126","author":"Brandt","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.omtn.2026.102843_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40478-019-0664-z","article-title":"A walk through tau therapeutic strategies","volume":"7","author":"Jadhav","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.omtn.2026.102843_bib6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40478-018-0637-7","article-title":"Different tau species lead to heterogeneous tau pathology propagation and misfolding","volume":"6","author":"Dujardin","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.omtn.2026.102843_bib7","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.neuron.2023.04.020","article-title":"Synaptic oligomeric tau in Alzheimer\u2019s disease \u2014 A potential culprit in the spread of tau pathology through the brain","volume":"111","author":"Colom-Cadena","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2026.102843_bib8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.tins.2014.08.004","article-title":"Lost after translation: missorting of Tau protein and consequences for Alzheimer disease","volume":"37","author":"Zempel","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.omtn.2026.102843_bib9","article-title":"Mobility and subcellular localization of endogenous, gene-edited Tau differs from that of over-expressed human wild-type and P301L mutant Tau","volume":"6","author":"Xia","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2026.102843_bib10","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1042\/BST0380967","article-title":"From tau phosphorylation to tau aggregation: what about neuronal death?","volume":"38","author":"Bu\u00e9e","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.omtn.2026.102843_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-012-1038-9","article-title":"Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy","volume":"124","author":"Crimins","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.omtn.2026.102843_bib12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.omtn.2026.102843_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","article-title":"Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice","volume":"6","author":"Lasagna-Reeves","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.omtn.2026.102843_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3233\/JAD-2008-14415","article-title":"Is tau aggregation toxic or protective?","volume":"14","author":"Congdon","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.omtn.2026.102843_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00321","article-title":"Disentangling tau: One protein, many therapeutic approaches","volume":"21","author":"Lane-Donovan","year":"2024","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.omtn.2026.102843_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107842","article-title":"Disease-modifying strategies in primary tauopathies","volume":"167","author":"R\u00f6sler","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.omtn.2026.102843_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe1611","article-title":"Persistent repression of tau in the brain using engineered zinc finger protein transcription factors","volume":"7","author":"Wegmann","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtn.2026.102843_bib18","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.cell.2021.03.032","article-title":"Reducing acetylated tau is neuroprotective in brain injury","volume":"184","author":"Shin","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.102843_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2026.102843_bib20","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/brain\/awz100","article-title":"Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody","volume":"142","author":"Albert","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2026.102843_bib21","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ymthe.2024.01.033","article-title":"Tau reduction with artificial microRNAs modulates neuronal physiology and improves tauopathy phenotypes in mice","volume":"32","author":"Facal","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.102843_bib22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.celrep.2018.03.079","article-title":"Modulation of Tau isoforms imbalance precludes tau pathology and cognitive decline in a mouse model of tauopathy","volume":"23","author":"Esp\u00edndola","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2026.102843_bib23","doi-asserted-by":"crossref","first-page":"10741","DOI":"10.1523\/JNEUROSCI.1065-09.2009","article-title":"Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology","volume":"29","author":"Polydoro","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtn.2026.102843_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.951384","article-title":"SMaRT modulation of tau isoforms rescues cognitive and motor impairments in a preclinical model of tauopathy","volume":"10","author":"Mu\u00f1iz","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.omtn.2026.102843_bib25","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1093\/brain\/awab130","article-title":"Tau mis-splicing correlates with motor impairments and striatal dysfunction in a model of tauopathy","volume":"144","author":"Damianich","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2026.102843_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-\u03b2 toxicity in Alzheimer's disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2026.102843_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41467-017-00618-0","article-title":"Tau exacerbates excitotoxic brain damage in an animal model of stroke","volume":"8","author":"Bi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2026.102843_bib28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid \u03b2\u2013induced deficits in an Alzheimer\u2019s disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.102843_bib29","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nn.4328","article-title":"Neuronal activity enhances tau propagation and tau pathology in vivo","volume":"19","author":"Wu","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtn.2026.102843_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/science.abb8255","article-title":"Tau: enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies","volume":"371","author":"Chang","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.102843_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109855","article-title":"Tau reduction affects excitatory and inhibitory neurons differently, reduces excitation\/inhibition ratios, and counteracts network hypersynchrony","volume":"37","author":"Chang","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2026.102843_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm5527","article-title":"Tau ablation in excitatory neurons and postnatal tau knockdown reduce epilepsy, SUDEP, and autism behaviors in a Dravet syndrome model","volume":"14","author":"Shao","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2026.102843_bib33","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41583-018-0054-8","article-title":"Rodent models for Alzheimer disease","volume":"19","author":"G\u00f6tz","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.omtn.2026.102843_bib34","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.15252\/embj.201592748","article-title":"Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity","volume":"34","author":"Wegmann","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.omtn.2026.102843_bib35","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1523\/JNEUROSCI.3439-13.2014","article-title":"Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging","volume":"34","author":"Ma","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtn.2026.102843_bib36","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3233\/JAD-170600","article-title":"Our Working Point of View of Tau Protein","volume":"62","author":"Avila","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.omtn.2026.102843_bib37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fendo.2020.00124","article-title":"Behavioral Abnormalities in Knockout and Humanized Tau Mice","volume":"11","author":"Gon\u00e7alves","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.omtn.2026.102843_bib38","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","article-title":"Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer\u2019s disease: a phase 1b, randomized, placebo-controlled trial","volume":"29","author":"Mummery","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2026.102843_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv1246","article-title":"Improved knockdown from artificial microRNAs in an enhanced miR-155 backbone: a designer\u2019s guide to potent multi-target RNAi","volume":"44","author":"Fowler","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2026.102843_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102057","article-title":"Efficacy and safety of a SOD1-targeting artificial miRNA delivered by AAV9 in mice are impacted by miRNA scaffold selection","volume":"34","author":"Chen","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.102843_bib41","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.tig.2022.02.006","article-title":"Emerging concepts of miRNA therapeutics: from cells to clinic","volume":"38","author":"Diener","year":"2022","journal-title":"Trends Genet."},{"key":"10.1016\/j.omtn.2026.102843_bib42","doi-asserted-by":"crossref","first-page":"e1640","DOI":"10.1002\/wrna.1640","article-title":"Artificial miRNAs as therapeutic tools: Challenges and opportunities","volume":"12","author":"Kotowska-Zimmer","year":"2021","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.omtn.2026.102843_bib43","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1471-4159.2003.01879.x","article-title":"Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms","volume":"86","author":"Andorfer","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.omtn.2026.102843_bib44","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nmeth911","article-title":"On the art of identifying effective and specific siRNAs","volume":"3","author":"Pei","year":"2006","journal-title":"Nat. Methods"},{"key":"10.1016\/j.omtn.2026.102843_bib45","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/978-1-62703-709-9_22","article-title":"Bioinformatics of siRNA design","volume":"1097","author":"Tafer","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtn.2026.102843_bib46","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0559-20.2021","article-title":"Fyn knockdown prevents levodopa-induced dyskinesia in a mouse model of Parkinson\u2019s disease","volume":"8","author":"Bordone","year":"2021","journal-title":"eNeuro"},{"key":"10.1016\/j.omtn.2026.102843_bib47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0896-6273(00)80525-5","article-title":"Reliability and state dependence of pyramidal cell-interneuron synapses in the hippocampus: an ensemble approach in the behaving rat","volume":"21","author":"Csicsvari","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2026.102843_bib48","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41380-018-0260-9","article-title":"SSRIs target prefrontal to raphe circuits during development modulating synaptic connectivity and emotional behavior","volume":"24","author":"Soiza-Reilly","year":"2019","journal-title":"Mol. Psychiatr."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126000144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:19:21Z","timestamp":1780103961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126000144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2162253126000144"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102843","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial microRNAs targeting tau enable post-symptomatic functional recovery in aged tauopathy mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.102843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102843"}}